Remove 2004 Remove IP Remove Technology Remove Viral
article thumbnail

Out of the Crisis #5, ANA Therapeutics: a possible COVID-19 treatment and prophylactic

Startup Lessons Learned

51:36) Scientific background on niclosamide, what we know about how it works to stop viral replication. (52:48) And while I didn't spend a great deal of time in research, I somehow pivoted into IP licensing, which led me to meet Nadja and we founded YourChoice Therapeutics together, and that's what led to the genesis of ANA Therapeutics.

article thumbnail

CEO Friday: Why we don’t hire.NET programmers

blog.expensify.com

Guess which technology we have the least trouble with. You have a CEO that clearly hasn’t taken the time to understand a technology platform. who forms technology biases based on old Visual Basic stereotypes or shallow interpretations of. ability based on one of many technologies. March 25, 2011 at 1:36 pm.

Java 107